22-40251193-A-C

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4BP6_ModerateBS1BS2

The NM_001162501.2(TNRC6B):​c.108A>C​(p.Lys36Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000383 in 1,535,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.00021 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00040 ( 0 hom. )

Consequence

TNRC6B
NM_001162501.2 missense

Scores

3
6
10

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 6.21

Publications

2 publications found
Variant links:
Genes affected
TNRC6B (HGNC:29190): (trinucleotide repeat containing adaptor 6B) Enables RNA binding activity. Involved in regulation of gene expression. Predicted to be located in cytosol. Predicted to be active in P-body and nucleoplasm. Implicated in subserous uterine fibroid and uterine fibroid. [provided by Alliance of Genome Resources, Apr 2022]
TNRC6B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • global developmental delay with speech and behavioral abnormalities
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.28448594).
BP6
Variant 22-40251193-A-C is Benign according to our data. Variant chr22-40251193-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 3026122.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00021 (32/152172) while in subpopulation NFE AF = 0.000294 (20/68042). AF 95% confidence interval is 0.000194. There are 0 homozygotes in GnomAd4. There are 10 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 32 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNRC6BNM_001162501.2 linkc.108A>C p.Lys36Asn missense_variant Exon 3 of 23 ENST00000454349.7 NP_001155973.1 Q9UPQ9-3
TNRC6BNM_015088.3 linkc.108A>C p.Lys36Asn missense_variant Exon 3 of 21 NP_055903.2 Q9UPQ9-1
TNRC6BNM_001024843.2 linkc.216A>C p.Lys72Asn missense_variant Exon 6 of 24 NP_001020014.1 Q9UPQ9-2A0A024R1N5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNRC6BENST00000454349.7 linkc.108A>C p.Lys36Asn missense_variant Exon 3 of 23 2 NM_001162501.2 ENSP00000401946.2 Q9UPQ9-3
TNRC6BENST00000335727.13 linkc.108A>C p.Lys36Asn missense_variant Exon 3 of 21 1 ENSP00000338371.8 Q9UPQ9-1
TNRC6BENST00000402203.5 linkc.216A>C p.Lys72Asn missense_variant Exon 6 of 24 1 ENSP00000384795.1 Q9UPQ9-2
TNRC6BENST00000301923.13 linkc.216A>C p.Lys72Asn missense_variant Exon 6 of 24 5 ENSP00000306759.9 Q9UPQ9-2

Frequencies

GnomAD3 genomes
AF:
0.000210
AC:
32
AN:
152172
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000294
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000121
AC:
18
AN:
148536
AF XY:
0.000101
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000291
Gnomad OTH exome
AF:
0.000240
GnomAD4 exome
AF:
0.000402
AC:
556
AN:
1383542
Hom.:
0
Cov.:
28
AF XY:
0.000357
AC XY:
244
AN XY:
682714
show subpopulations
African (AFR)
AF:
0.0000324
AC:
1
AN:
30836
American (AMR)
AF:
0.00
AC:
0
AN:
34254
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24914
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35558
South Asian (SAS)
AF:
0.00
AC:
0
AN:
77466
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48050
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4716
European-Non Finnish (NFE)
AF:
0.000479
AC:
513
AN:
1070500
Other (OTH)
AF:
0.000734
AC:
42
AN:
57248
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.404
Heterozygous variant carriers
0
25
50
75
100
125
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000210
AC:
32
AN:
152172
Hom.:
0
Cov.:
31
AF XY:
0.000135
AC XY:
10
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.000265
AC:
11
AN:
41432
American (AMR)
AF:
0.00
AC:
0
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000294
AC:
20
AN:
68042
Other (OTH)
AF:
0.000478
AC:
1
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000358
Hom.:
0
Bravo
AF:
0.000246
ExAC
AF:
0.0000366
AC:
3

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TNRC6B: BP1, BS1:Supporting -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.84
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.42
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.024
.;.;T;.
Eigen
Uncertain
0.62
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.95
D;.;D;D
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.28
T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Uncertain
2.2
.;.;M;M
PhyloP100
6.2
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
0.050
N;N;N;N
REVEL
Benign
0.11
Sift
Pathogenic
0.0
D;D;D;D
Sift4G
Benign
0.44
T;T;D;D
Polyphen
0.99
D;D;D;D
Vest4
0.52
MutPred
0.30
.;.;Loss of methylation at K36 (P = 7e-04);Loss of methylation at K36 (P = 7e-04);
MVP
0.42
MPC
0.17
ClinPred
0.20
T
GERP RS
5.7
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.6
Varity_R
0.26
gMVP
0.22
Mutation Taster
=38/62
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs772968885; hg19: chr22-40647197; API